REVOFIL™ ULTRA

REVOFIL ULTRA is an advanced deep touch dermal filler designed to treat very deep wrinkles, restore facial volume, and redefine facial contours. Developed using cross-linked hyaluronic acid (HA) enhanced with patented peptides, this filler delivers long-lasting aesthetic improvements while promoting skin regeneration.

It is engineered for enhanced viscoelasticity, durability, and resistance to enzymatic degradation, ensuring extended in vivo longevity compared to conventional fillers. REVOFIL ULTRA is ideal for volumizing areas such as the cheeks, chin, and jawline, offering visible results for up to 12 months per treatment session.

• Designed for thick skin and deep dermal layers
• Combines HA (23 mg/mL) with CG-Boostrin peptide
• Clinically tested with 99% satisfaction rate
• Injection areas include: forehead, nose bridge, nasolabial folds, marionette lines, jawline

REVOFIL ULTRA is injected into the deep dermis or subcutaneous tissue using a 27G 1/2” needle. The procedure is performed by licensed professionals using standard aseptic techniques.

Key Features:

• Deep placement ensures long-lasting volume restoration
• Recommended for facial contouring and volumization

Protocol Details:

• Needle size: 27G 1/2”
• Injection depth: Deep dermis to subcutaneous layer
• Injection sites: Forehead, cheeks, jawline, chin, nasolabial folds
• Volume per syringe: 1 mL
• Touch-up timing: Typically after 10–12 months

REVOFIL ULTRA is indicated for patients seeking correction of deep wrinkles, facial contour reshaping, and volumization in areas with thicker dermal tissue.

Indications:

• Correction of very deep facial wrinkles
• Augmentation of cheeks, chin, and jawline
• Facial volume restoration
• Harmonizing facial contours

Contraindications:

• Hypersensitivity to hyaluronic acid or lidocaine (if present)
• Active skin infections at the injection site
• Autoimmune disorders
• Pregnancy and breastfeeding

Side Effects:

• Mild erythema, swelling, or bruising at the injection site
• Rare: Nodules or allergic reactions

REVOFIL ULTRA contains a unique blend of high-purity cross-linked hyaluronic acid and a patented bioactive peptide designed to improve product durability and skin regeneration.

• Hyaluronic Acid concentration: 23 mg/mL
• Cross-linking agent: BDDE
• Bioactive peptide: CG-Boostrin
• Formulation: Viscoelastic gel, stabilized for long duration
• Preservatives: None

CG-Boostrin peptide enhances HA resistance to hyaluronidase, extending the filler’s presence in tissue and stimulating collagen and HA synthesis in fibroblasts.

Each unit of REVOFIL ULTRA is professionally packaged to ensure sterility and safety during transport and handling.

• 1 mL prefilled syringe
• Sterile needle (27G 1/2”) included
• Blister pack for hygienic protection
• Instruction leaflet with clinical guidance

All items are individually packed to ensure product integrity and minimize contamination risks.

REVOFIL ULTRA is generally well tolerated, with side effects being rare and typically mild. Clinical studies report a 99% satisfaction rate with minimal adverse reactions.

Common Side Effects:

• Temporary redness
• Mild swelling or bruising
• Itching at the injection site

Less Common:

• Nodules
• Delayed hypersensitivity
• Discoloration or firmness in rare cases

Most side effects resolve within a few days post-treatment.

To maintain stability and efficacy, REVOFIL ULTRA must be stored under controlled conditions.

• Storage temperature: 2–25°C (36–77°F)
• Avoid freezing
• Keep out of direct sunlight
• Use before the expiration date printed on the packaging

Once opened, the product should be used immediately and any unused gel should be discarded.